Application 022138
- Type
- NDA
- Sponsor
- SANOFI AVENTIS US
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOVENOX | ENOXAPARIN SODIUM | INJECTABLE; INJECTION | 100MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Meitheal Pharmaceuticals Inc. | adfc2b23-00a5-4f05-a08b-83087e1e4843 | 2024-02-05 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Italfarmaco SpA | b4d9e4d4-4fdb-48d6-a169-7bc5eebc51e9 | 2022-11-05 | ENOXAPARIN SODIUM | |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Amphastar Pharmaceuticals, Inc. | 3e6bf2b3-9339-4104-bda3-ad86a1949703 | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.